Louise Rodino-Klapac - 17 Nov 2022 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Head of R&D, CSO
Signature
/s/ Ryan Brown, as Attorney-in-Fact for Louise Rodino-Klapac
Issuer symbol
SRPT
Transactions as of
17 Nov 2022
Net transactions value
-$456,978
Form type
4
Filing time
21 Nov 2022, 19:02:02 UTC
Previous filing
08 Mar 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Tax liability $456,978 -4,211 -5.8% $108.52 67,998 17 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 16, 2021.
F2 Amount of Securities Beneficially Owned includes 98 shares purchased under the Company's registered Employee Stock Purchase Plan on August 31, 2022.